[64th Congress of the American College of Rheumatology, Philadelphia, October 28-November 2, 2000].
Hachulla
E
E
Service de médecine interne, hôpital Claude-Huriez, place de Verdun, 59037 Lille, France.
D000686:Amyloidosis / Q000628:therapy; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001528:Behcet Syndrome / Q000188:drug therapy; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D011111:Polymyalgia Rheumatica / Q000175:diagnosis; D011720:Pyrazoles; D012219:Rheumatology; D012595:Scleroderma, Systemic / Q000175:diagnosis; D012859:Sjogren's Syndrome / Q000175:diagnosis; D013449:Sulfonamides / Q000627:therapeutic use
D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib